Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03656133 · ClinicalTrials.gov registry record · NA
Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT03656133 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 55 participants.
The verdict
NCT03656133, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study is to determine whether a mathematical model can be used to choose a radiation delivery method to improve the rate of a rapid response.
Interventions
- RADIATION Radiotherapy fractionation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2018-09-26 |
| Est. Completion | 2024-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03656133
The ClinicalTrials.gov registry entry for NCT03656133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiotherapy fractionation is the first listed.
NCT03656133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03656133 about?
NCT03656133 is a clinical study titled "Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers". This study is to determine whether a mathematical model can be used to choose a radiation delivery method to improve the rate of a rapid response.
What is the current status of trial NCT03656133?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2018-09-26. Estimated completion is 2024-03-26.
What interventions are being tested in trial NCT03656133?
The interventions under investigation include: Radiotherapy fractionation (RADIATION).
Who is sponsoring clinical trial NCT03656133?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.